Article
Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma.
Frontiers in immunology - 1 Jan 2021
Zheng Xiaoqin, Jin Wenjie, Wang Shanshan, Ding Huiguo
Abstract excerpt
Primary liver cancer (PLC) is one of the most common malignancies in China, where it ranks second in mortality and fifth in morbidity. Currently, liver transplantation, hepatic tumor resection, radiofrequency ablation, and molecular-targeted agents are the major treatments for hepatocellular carcinoma (HCC). Overall, HCC has a poor survival rate and a high recurrence rate. Tumor-infiltrating lymphocytes (TILs)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
